Start for free
Start for free
TD

The Duke of Bedford

Description

The Duke of Bedford

Investor Profile

The Duke of Bedford has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series Unknown (67%)
  • Seed (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does The Duke of Bedford frequently co-invest with?

Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
Agent Capital
Agent Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Celgene
Celgene
North America, New Jersey, United States, Summit
Co-Investments: 2
Good Growth Capital
Good Growth Capital
North America, South Carolina, United States, Charleston
Co-Investments: 2
ShangPharma Innovation
ShangPharma Innovation
North America, California, United States, San Francisco
Co-Investments: 1
GreatPoint Ventures
GreatPoint Ventures
North America, Michigan, United States, New Haven
Co-Investments: 1

Which angels does The Duke of Bedford often collaborate with?

Tim Disney
Shared Deals: 2

What are some of recent deals done by The Duke of Bedford?

Skyhawk Therapeutics

Waltham, Massachusetts, United States

Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.

BiotechnologyTherapeutics
Series UnknownJun 26, 2018
Amount Raised: $40,000,000
Skyhawk Therapeutics

Waltham, Massachusetts, United States

Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.

BiotechnologyTherapeutics
SeedJan 23, 2018
Amount Raised: $8,000,000
Dragonfly Therapeutics

Waltham, Massachusetts, United States

Dragonfly Therapeutics is a clinical-stage biotech developing novel immunotherapies that harness the innate immune system to treat disease.

BiotechnologyTherapeutics
Series UnknownMay 15, 2017
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator